Skip to main content

Kyprolis 30 mg lyophilized powder for injection Images

Generic Name: carfilzomib

This medication has been identified as Kyprolis 30 mg lyophilized powder for injection. It is supplied by Onyx Pharmaceuticals, Inc.

Kyprolis is used in the treatment of Multiple Myeloma and belongs to the drug class proteasome inhibitors. There is positive evidence of human fetal risk during pregnancy. Kyprolis 30 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Kyprolis 30 mg lyophilized powder for injection medicine

Kyprolis

Generic Name
carfilzomib
Strength
30 mg lyophilized powder for injection
Availability
Prescription only
Drug Class
Proteasome inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Onyx Pharmaceuticals, Inc.
National Drug Code (NDC)
76075-0102

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.